Novel Therapy Target in Metastatic Prostate Cancer

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2028

Conditions

Prostate Neoplasms

Interventions

OTHER

Tissue

Tissue will be derived from patients during a standard of care procedure

Trial Locations (1)

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER